Human immunodeficiency virus-1 induces host genomic R-loops and preferentially integrates its genome near the R-loop regions

  1. Kiwon Park
  2. Dohoon Lee
  3. Jiseok Jeong
  4. Sungwon Lee
  5. Sun Kim
  6. Kwangseog Ahn  Is a corresponding author
  1. Center for RNA Research, Institute for Basic Science, Republic of Korea
  2. School of Biological Sciences, Seoul National University, Republic of Korea
  3. Bioinformatics Institute, Seoul National University, Republic of Korea
  4. BK21 FOUR Intelligence Computing, Seoul National University, Republic of Korea
  5. Department of Computer Science and Engineering, Seoul National University, Republic of Korea
  6. SNU Institute for Virus Research, Seoul National University, Republic of Korea
11 figures, 2 tables and 1 additional file

Figures

Figure 1 with 6 supplements
HIV-1 infection induces genomic R-loop accumulation in cells at early post-infection.

(A) Summary of experimental design for DNA-RNA immunoprecipitation followed by cDNA conversion coupled with high-throughput sequencing (DRIPc-seq) in HeLa cells, primary CD4+ T cells, and Jurkat …

Figure 1—source data 1

Original dot blots for Figure 1D, indicate the relevant dots and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig1-data1-v1.zip
Figure 1—source data 2

Original files for dot blot analysis are displayed in Figure 1D.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig1-data2-v1.zip
Figure 1—figure supplement 1
Primary CD4+ T cells sorting strategies and GFP-HIV-1 infection.

(A) Gating strategy used to determine the efficiency of CD4+ T cells sorting from human PBMC. Pre-sorted PBMCs were staining with FITC-conjugated anti-CD4 and subjected fto positive CD4+ T cell …

Figure 1—figure supplement 2
Chromosomal position and DNA-RNA immunoprecipitation followed by cDNA conversion coupled with high-throughput sequencing (DRIPc-seq) signal for referenced R-loop-positive and –negative regions in HIV-1 infected HeLa cells.
Figure 1—figure supplement 3
Chromosomal position and DNA-RNA immunoprecipitation followed by cDNA conversion coupled with high-throughput sequencing (DRIPc-seq) signal for referenced R-loop-positive and –negative regions in HIV-1 infected primary CD4+ T cells.
Figure 1—figure supplement 4
Chromosomal position and DNA-RNA immunoprecipitation followed by cDNA conversion coupled with high-throughput sequencing (DRIPc-seq) signal for referenced R-loop-positive and –negative regions in HIV-1 infected Jurkat cells.
Figure 1—figure supplement 5
Genome browser screenshot over the HIV-1-induced R-loop forming positive or negative genomic regions.

(A–C), Genome browser screenshot over the P1 (A), P2 (B), and P3 (C) HIV-1 induced R-loop-positive chromosomal regions showing results from DNA-RNA immunoprecipitation followed by cDNA conversion …

Figure 1—figure supplement 6
Host cellular R-loop induction by HIV-1 infection is host-genome specific.

(A) DRIP followed by real-time polymerase chain reaction (DRIP-qPCR) using the anti-S 9.6 antibody at P1, P2, P3, N1, and N2 in HIV-1-infected cells with multiplicity of infection (MOI) of 0.6 …

Figure 1—figure supplement 6—source data 1

Original dot blots for Figure 1—figure supplement 6B, indicating the relevant dots and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig1-figsupp6-data1-v1.zip
Figure 1—figure supplement 6—source data 2

Original files for dot blot analysis are displayed in Figure 1—figure supplement 6B.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig1-figsupp6-data2-v1.zip
Figure 2 with 2 supplements
HIV-1-induced R-loops are enriched at both transcriptionally active and silent regions.

(A) Distribution of DNA-RNA immunoprecipitation followed by cDNA conversion coupled with high-throughput sequencing (DRIPc-seq) peak lengths for HIV-1-infected HeLa cells, primary CD4+ T cells, and …

Figure 2—figure supplement 1
R-loop induction by HIV-1 infection does not follow transcriptome changes in HeLa cells.

(A) Line graphs and heat maps representing expression levels of indicated repetitive elements (SINE, right; LINE, middle; LTR, left) at the indicated hpi of HIV-1 in HeLa cells. Data are presented …

Figure 2—figure supplement 2
RNA-seq analysis of relative gene expression levels of P1-3 and N1,2 R-loop regions.
Figure 3 with 1 supplement
R-loop inducible cell line model directly addresses R-loop-mediated HIV-1 integration site selection.

(A) Summary of the experimental design for R-loop inducible cell lines, pgR-poor and pgR-rich. (B) Gene expression of ECFP (gray) and mAIRN (red), as measured using RT-qPCR in pgR-poor or pgR-rich …

Figure 3—figure supplement 1
PiggyBac transposon-transposase insertion of R-loop forming and non-R-loop forming sequences in HeLa cells.

(A) Copy the number of piggyBac transposon inserts in each cell line constructed by transfecting the transposon vector and transposase-expressing vector. (B and C) Fold induction of gene expression …

HIV-1 prefers host genomic R-loop regions for its viral cDNA integration.

(A) Bar graphs showing the quantified number of HIV-1 integration sites per Mb pairs in total regions of 30 kb windows centered on DNA-RNA immunoprecipitation followed by cDNA conversion coupled …

Figure 5 with 1 supplement
HIV-1 integrase proteins directly bind to host genomic R-loops.

(A) Representative gel images for electrophoretic mobility shift assay (EMSA) of Sso7d-tagged HIV-1-integrase (E152Q) with R-loop and dsDNA, 10 nM nucleic acid substrate was incubated with …

Figure 5—source data 1

Original gel image for Figure 5A, indicating the relevant bands and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data1-v1.zip
Figure 5—source data 2

Original files for electrophoretic mobility shift assay (EMSA) analysis are displayed in Figure 5A.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data2-v1.zip
Figure 5—source data 3

Original western blots for Figure 5C, indicate the relevant bands and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data3-v1.zip
Figure 5—source data 4

Original files for western blot analysis are displayed in Figure 5C.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data4-v1.zip
Figure 5—source data 5

Original western blots for Figure 5D, indicate the relevant bands and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data5-v1.zip
Figure 5—source data 6

Original files for western blot analysis are displayed in Figure 5D.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data6-v1.zip
Figure 5—source data 7

Original western blots for Figure 5E, indicate the relevant bands and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data7-v1.zip
Figure 5—source data 8

Original files for western blot analysis are displayed in Figure 5E.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data8-v1.zip
Figure 5—source data 9

Original dot blots for Figure 5F, indicate the relevant dots and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data9-v1.zip
Figure 5—source data 10

Original files for dot blot analysis are displayed in Figure 5F.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-data10-v1.zip
Figure 5—figure supplement 1
HIV-1 integrase proteins directly bind to host genomic R-loops.

(A) Representative gel images for electrophoretic mobility shift assay (EMSA) of Sso7d-tagged HIV-1-integrase (E152Q) with different types of nucleic acids substrates (R:D+ssDNA and Hybrid). 100 nM …

Figure 5—figure supplement 1—source data 1

Original dot blots for Figure 5—figure supplement 1B, indicating the relevant dots and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-figsupp1-data1-v1.zip
Figure 5—figure supplement 1—source data 2

Original files for dot blot analysis are displayed in Figure 5—figure supplement 1B.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-figsupp1-data2-v1.zip
Figure 5—figure supplement 1—source data 3

Original western blots for Figure 5—figure supplement 1D, indicating the relevant bands and treatments.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-figsupp1-data3-v1.zip
Figure 5—figure supplement 1—source data 4

Original files for western blot analysis are displayed in Figure 5—figure supplement 1D.

https://cdn.elifesciences.org/articles/97348/elife-97348-fig5-figsupp1-data4-v1.zip
Author response image 1
Representative flow cytometry histograms of VSV-G-pseudotyped HIV-1-EGFP-infected HeLa cells at an MOI of 1, harvested at 48 hpi.

The cells were treated with DMSO, the indicated doses of nevirapine (NVP) (A) or indicated doses of raltegravir (RAL) (B) for 24 h before infection.

Author response image 2
Genome browser screenshot over the chromosomal regions in 20-kb windows centered on human AIRN showing results from DRIPc-seq in the indicated HIV-1-infected cells (blue, 0 hpi; yellow, 3 hpi; green, 6 hpi; red, 12 hpi).
Author response image 3
Dot blot analysis of cellular R-loops in cells infected with different virus particles.

(A) Dot blot analysis of the R-loop in gDNA extracts from HIV-1 infected U2OS cells with MOI of 0.6 harvested at 6 hpi. The gDNA extracts were incubated with or without RNase H in vitro before …

Author response image 4
Gating strategy used to determine HIV-1-infectivity in HeLa cells at 48 hpi.

Cells were infected with a known p24 antigen content in the stock of the VSV-G-pseudotyped HIV-1-EGFP-virus. The percentages of GFP-positive cell population are indicated.

Author response image 5
Bar graph indicating DRIPc-seq peak counts for HIV-1-infected primary CD4+ T cells harvested at the indicated hours post infection (hpi).

Pre-immunoprecipitated samples were untreated (−) or treated (+) with RNase H, as indicated. Each dot corresponds to an individual data set from two biologically independent experiments.

Author response image 6
Bar graphs showing the quantified number of HIV-1 integration sites per Mb pair in total regions of 30-kb windows centered on DRIPc-seq peaks from HIV-1 infected HeLa cells and primary CD4+ T cells (magenta) or non-R-loop region in the cellular genome (gray).

Each dot corresponds to an individual data set from two biologically independent experiments.

Tables

Appendix 1—key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Sequence-based reagentP1 FwdThis paperTTATAAGTCAGCCTCCAGGATCAA
Sequence-based reagentP1 RevThis paperTTCAGGTCTAGGCAGTCTGA
Sequence-based reagentP2 FwdThis paperGGACAGATGACAGGGTCGC
Sequence-based reagentP2 RevThis paperATGAGGAAGACCCCCTCGG
Sequence-based reagentP3 FwdThis paperCTCTGTGTAACGCTGGTGCT
Sequence-based reagentP3 RevThis paperACACGCTTCTGACCACTAAGG
Sequence-based reagentN1 FwdThis paperTTGGCCCTACTGAATGATTGGT
Sequence-based reagentN1 RevThis paperTTAAGGCATGCTCAGGCGA
Sequence-based reagentN2 FwdThis paperTGAGATTTCAGGTTCCATGATTTG
Sequence-based reagentN2 RevThis paperTGCTCAGTGTTCTAATTTCCCTGT
Sequence-based reagentβ-actin FwdThis paperAGAGCTACGAGCTGCCTGAC
Sequence-based reagentβ-actin RevThis paperAGCACTGTGTTGGCGTACAG
Sequence-based reagentSH49 (ECFP Fwd)Hamperl et al., 2017TGGTTTGTCCAAACTCATCAA
Sequence-based reagentSH40 (mAIRN Fwd)Hamperl et al., 2017;CGAGAGAGGCTAAGGGTGAA
Sequence-based reagentSH21 (ECFP/mAIRN Rev)Hamperl et al., 2017; Braun, 2018ACATGGTCCTGCTGGAGTTC
Sequence-based reagentRT-qPCR P1 (TOR1AIP2) FwdThis paperCCTTGGTCTTTCCCACTTGAGTG
Sequence-based reagentRT-qPCR P1 (TOR1AIP2) RevThis paperGCAGGGTTAAAACCAGCTACTCG
Sequence-based reagentRT-qPCR P2 (DVL1) FwdThis paperGCATAACCGACTCCACCATGTC
Sequence-based reagentRT-qPCR P2 (DVL1) RevThis paperGATGGAGCCAATGTAGATGCCG
Sequence-based reagentRT-qPCR P3 (PKN2) FwdThis paperGCATCACCAACACTAAGTCCACG
Sequence-based reagentRT-qPCR P3 (PKN2) RevThis paperGCTTTTGACCGTCCAGGGACAT
Sequence-based reagentRT-qPCR N2 (CDK5RAP1) FwdThis paperAGAGTGGAAGCAGCCGTGTGTT
Sequence-based reagentRT-qPCR N2 (CDK5RAP1) RevThis paperGATCTTCCTCCGTCTCACCACA
Sequence-based reagentPCR primer 1.0 P5Sanz and Chédin, 2019AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGA
Sequence-based reagentPCR primer 2.0 P7Sanz and Chédin, 2019CAAGCAGAAGACGGCATACGAGAT
Sequence-based reagentIndex Adapter 1IlluminaHeLa 0hpi Input replicate 1; Jurkat 0hpi Input replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 2IlluminaHeLa 3hpi Input replicate 1; Jurkat 3hpi Input replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 3IlluminaHeLa 6hpi Input replicate 1; Jurkat 6hpi Input replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACTTAGGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 4IlluminaHeLa 12hpi Input replicate 1; Jurkat 12hpi Input replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 5IlluminaHeLa 0hpi RNH-IP replicate 1; Jurkat 0hpi RNH-IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 6IlluminaHeLa 3hpi RNH-IP replicate 1; Jurkat 3hpi RNH-IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 7IlluminaHeLa 6hpi RNH-IP replicate 1; Jurkat 6hpi RNH-IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 8IlluminaHeLa 12hpi RNH-IP replicate 1; Jurkat 12hpi RNH-IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACACTTGAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 9IlluminaHeLa 0hpi RNH +IP replicate 1; Jurkat 0hpi RNH +IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACGATCAGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 10IlluminaHeLa 3hpi RNH +IP replicate 1; Jurkat 3hpi RNH +IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACTAGCTTATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 11IlluminaHeLa 6hpi RNH +IP replicate 1; Jurkat 6hpi RNH +IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACGGCTACATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 12IlluminaHeLa 12hpi RNH +IP replicate 1; Jurkat 12hpi RNH +IP replicate 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 13IlluminaJurkat 0hpi Input replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACAGTCAAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 14IlluminaJurkat 3hpi Input replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACAGTTCCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 15IlluminaJurkat 6hpi Input replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACATGTCAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 16IlluminaJurkat 12hpi Input replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCCGTCCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 17IlluminaJurkat 0hpi RNH-IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGTAGAGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 18IlluminaJurkat 3hpi RNH-IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGTCCGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 19IlluminaJurkat 6hpi RNH-IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGTGAAAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 20IlluminaJurkat 12hpi RNH-IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGTGGCCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 21IlluminaJurkat 0hpi RNH +IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGTTTCGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 22IlluminaJurkat 3hpi RNH +IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGTACGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 23IlluminaJurkat 6hpi RNH +IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGAGTGGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 24IlluminaJurkat 12hpi RNH +IP replicate 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGGTAGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 25IlluminaCD4 0hpi Input donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACACTGATATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 26IlluminaCD4 3hpi Input donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACATGAGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 27IlluminaCD4 6hpi Input donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACATTCCTATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 28IlluminaHeLa 0hpi Input replicate 2; CD4 12hpi Input donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAAAAGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 29IlluminaHeLa 3hpi Input replicate 2; CD4 0hpi RNH-IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAACTAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 30IlluminaHeLa 6hpi Input replicate 2; CD4 3hpi RNH-IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCACCGGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 31IlluminaHeLa 12hpi Input replicate 2; CD4 6hpi RNH-IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCACGATATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 32IlluminaHeLa 0hpi RNH-IP replicate 2; CD4 12hpi RNH-IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCACTCAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 33IlluminaHeLa 3hpi RNH-IP replicate 2; CD4 0hpi RNH +IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGGCGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 34IlluminaHeLa 6hpi RNH-IP replicate 2; CD4 3hpi RNH +IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCATGGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 35IlluminaHeLa 12hpi RNH-IP replicate 2; CD4 6hpi RNH +IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCATTTTATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 36IlluminaHeLa 0hpi RNH +IP replicate 2; CD4 12hpi RNH +IP donor 1GATCGGAAGAGCACACGTCTGAACTCCAGTCACCCAACAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 37IlluminaHeLa 3hpi RNH +IP replicate 2; CD4 0hpi Input donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGGAATATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 38IlluminaHeLa 6hpi RNH +IP replicate 2; CD4 3hpi Input donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTAGCTATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 39IlluminaHeLa 12hpi RNH +IP replicate 2; CD4 6hpi Input donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTATACATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 40IlluminaCD4 12hpi Input donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTCAGAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 41IlluminaCD4 0hpi RNH-IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACGACGACATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 42IlluminaCD4 3hpi RNH-IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTAATCGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 43IlluminaCD4 6hpi RNH-IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTACAGCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 45IlluminaCD4 12hpi RNH-IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCATTCATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 46IlluminaCD4 0hpi RNH +IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCCCGAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 47IlluminaCD4 3hpi RNH +IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCGAAGATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 48IlluminaCD4 6hpi RNH +IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCGGCAATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentIndex Adapter 49IlluminaCD4 12hpi RNH +IP donor 2GATCGGAAGAGCACACGTCTGAACTCCAGTCACAACAACATCTCGTATGCCGTCTTCTGCTTG
Sequence-based reagentAE5316Achuthan et al., 2018
First round LTR primerTGTGACTCTGGTAACTAGAGATCCCTC
Sequence-based reagentAE6380Achuthan et al., 2018
HeLa replicate 1 5dpi Linker short / HeLa replicate 1 pgR-poor DOX- Linker short / CD4 +donor 1 Linker shortTAGTCCCTTAAGCGGAG-NH2
Sequence-based reagentAE6381Achuthan et al., 2018HeLa replicate 1 5dpi Linker long / HeLa replicate 1 pgR-poor DOX- Linker long / CD4 +donor 1 Linker longGTAATACGACTCACTATAGGGCCTCCGCTTAAGGGAC
Sequence-based reagentAE6382Achuthan et al., 2018HeLa replicate 1 5dpi Linker primer / HeLa replicate 1 pgR-poor DOX- Linker primer / CD4 +donor 1 Linker primerCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGTAATACGACTCACTATAGGGC
Sequence-based reagentAE6404Achuthan et al., 2018HeLa replicate 1 5dpi Second round LTR primer / HeLa replicate 1 pgR-poor DOX- Second round LTR primer / CD4 +donor 1 Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCGATGTGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentAE6380Achuthan et al., 2018HeLa replicate 2 5dpi Linker short / HeLa replicate 2 pgR-poor DOX +Linker shortTAGTCCCTTAAGCGGAG-NH2
Sequence-based reagentAE6381Achuthan et al., 2018HeLa replicate 2 5dpi Linker long /HeLa replicate 2 pgR-poor DOX +Linker longGTAATACGACTCACTATAGGGCCTCCGCTTAAGGGAC
Sequence-based reagentAE6382Achuthan et al., 2018HeLa replicate 2 5dpi Linker primer / HeLa replicate 2 pgR-poor DOX +Linker primeCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGTAATACGACTCACTATAGGGC
Sequence-based reagentAE6404-1This paperHeLa replicate 2 5dpi Second round LTR primer / HeLa replicate 2 pgR-poor DOX +Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTTAGGCGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentAE6386Achuthan et al., 2018HeLa replicate 1 pgR-rich DOX- Linker short / CD4 +donor 2 Linker shortTACTATGACGGTGACGC-NH2
Sequence-based reagentAE6387Achuthan et al., 2018HeLa replicate 1 pgR-rich DOX- Linker long / CD4 +donor 2 Linker longGAGAATCCATGAGTATGCTCACGCGTCACCGTCATAG
Sequence-based reagentAE6388Achuthan et al., 2018HeLa replicate 1 pgR-rich DOX- Linker primer / CD4 +donor 2 Linker primerCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGAGAATCCATGAGTATGCTCAC
Sequence-based reagentAE6406Achuthan et al., 2018HeLa replicate 1 pgR-rich DOX- Second round LTR primer / CD4 +donor 2 Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTACAGTGGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentAE6456Achuthan et al., 2018HeLa replicate 1 pgR-poor DOX +Linker shortTAGACTGACGCAGTCTG-NH2
Sequence-based reagentAE6457Achuthan et al., 2018HeLa replicate 1 pgR-poor DOX +Linker longGACGTACATACTGATCGCATAGCAGACTGCGTCAGTC
Sequence-based reagentAE6458Achuthan et al., 2018HeLa replicate 1 pgR-poor DOX +Linker primerCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGACGTACATACTGATCGCATAG
Sequence-based reagentAE6405Achuthan et al., 2018HeLa replicate 1 pgR-poor DOX +Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGACCAGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentAE6386Achuthan et al., 2018
HeLa replicate 2 pgR-rich DOX +Linker shortTACTATGACGGTGACGC-NH2
Sequence-based reagentAE6387Achuthan et al., 2018HeLa replicate 2 pgR-rich DOX +Linker longGAGAATCCATGAGTATGCTCACGCGTCACCGTCATAG
Sequence-based reagentAE6388Achuthan et al., 2018HeLa replicate 2 pgR-rich DOX +Linker primerCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGAGAATCCATGAGTATGCTCAC
Sequence-based reagentAE6406-1This paperHeLa replicate 2 pgR-rich DOX +Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGCCAATGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentAE6456Achuthan et al., 2018HeLa replicate 3 pgR-rich DOX- Linker shortTAGACTGACGCAGTCTG-NH2
Sequence-based reagentAE6457Achuthan et al., 2018HeLa replicate 3 pgR-rich DOX- Linker longGACGTACATACTGATCGCATAGCAGACTGCGTCAGTC
Sequence-based reagentAE6458Achuthan et al., 2018HeLa replicate 3 pgR-rich DOX- Linker primerCAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGACGTACATACTGATCGCATAG
Sequence-based reagentAE6411Achuthan et al., 2018
HeLa replicate 3 pgR-rich DOX- Second round LTR primerAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGTTCCGAGATCCCTCAGACCCTTTTAGTCAG
Sequence-based reagentR-loop oligo1*Kang et al., 2021R-loop; R:D+ssDNA5’-[Cy3]-GCC AGG GAC GAG GTG AAC CTG CAG GTG GGC GGC TAC TAC TTA GAT GTC ATC CGA GGC TTA TTG GTA GAA TTC GGC AGC GTC ATG C GA CGG C-3’
Sequence-based reagentR-loop oligo2*Kang et al., 2021R-loop; dsDNA5’-GCC GTC GCA TGA CGC TGC CGA ATT CTA CCA CGC GAT TCA TAC CTG TCG TGC CAG CTG CTT TGC CCA CCT GCA GGT TCA CCT CGT CCC TGG C-3’
Sequence-based reagentR-loop RNAKang et al., 2021R-loop; R:D+ssDNA5’-[Cy5]-GCA GCU GGC ACG ACA GGU AUG AAU C-3’
Sequence-based reagentHomoduplexKang et al., 2021dsDNA5’-[Cy3]-GCC AGG GAC GAG GTG AAC CTG CAG GTG GGC AAA GCA GCT GGC ACG ACA GGT ATG AAT CGC GTG GTA GAA TTC GGC AGC GTC ATG CGA CGG C-3’
Sequence-based reagentHybrid DNAKang et al., 2021Hybrid5’-CCC ATA CCG TAT AAC
CAT TTG GCT GTC CAA GCT CCG GGT-3’
Sequence-based reagentHybrid RNAKang et al., 2021Hybrid5’-[Cy5]-ACC CGG AGC UU
G GAC AGC CAA AUG GU
U AUA CGG UAU GGG-3’
Sequence-based reagentoligo 5Kang et al., 2021R:D+ssDNA5′GCAGTAGCATGACGCTGCTGAATTCTACCACGCTATGCT CTCGTCTAGGTTCACTCCGT CCCTGCGATTCATACCTGTCGTGCCAGCTGC
OtherJurkat integration siteLi et al., 2020bSRR12322252Source data
OtherTSA-seq_SPADChen et al., 2018SRR3538917, SRR3538918, SRR3538919, SRR3538920Source data
OtherSPIN (Spatial Position Inference of the Nuclear genome) annotation of speckleWang et al., 2020https://github.com/ma-compbio/SPIN; ma-compbio, 2020Source data
OtherLADsMeuleman et al., 2013GSE22428Source data
Author response table 1
DRIPc-seq peak length and Chi-square p-value in CD4+ T cells from individual donor 1 and 2.
Total DRIPc-seq peak length
(replicate 1, bp)
Total DRIPc-seq peak length
(replicate 2, bp)
Total DRIPc-seq peak length
(overalp, bp)
Chi-square
p-value
Ohpi19106094722514540640p < 1e-308
3hpi36308593308270835457p < 1e-308
6hpi419588784962661485568p < 1e-308
12hpi4323824137144021903473p < 1e-308

Additional files

Download links